Synthetic Biology Journal ›› 2022, Vol. 3 ›› Issue (4): 709-727.DOI: 10.12211/2096-8280.2022-001
• Invited Review • Previous Articles Next Articles
Daixu WEI(), Hailun GONG, Xuwei ZHANG
Received:
2022-01-08
Revised:
2022-04-26
Online:
2022-09-08
Published:
2022-08-31
Contact:
Daixu WEI
通讯作者:
魏岱旭
作者简介:
基金资助:
CLC Number:
Daixu WEI, Hailun GONG, Xuwei ZHANG. Biosynthesis of antimicrobial peptides and its medical application[J]. Synthetic Biology Journal, 2022, 3(4): 709-727.
魏岱旭, 龚海伦, 张旭维. 抗菌肽的生物合成及医学应用[J]. 合成生物学, 2022, 3(4): 709-727.
Add to citation manager EndNote|Ris|BibTeX
URL: https://synbioj.cip.com.cn/EN/10.12211/2096-8280.2022-001
Expression system and engineered microorganism | Antimicrobial peptides | References |
---|---|---|
Prokaryotic | ||
E. coli | Cecropin | [ |
Perinerin | [ | |
Adenoregulin | [ | |
Abaecin | [ | |
Hep-A200 | [ | |
MLH | [ | |
Hal18 | [ | |
Plectasin | [ | |
Lactoferricin | [ | |
Buforin II | [ | |
B.subtilis | Cecropin AD | [ |
Cathelicidin-BF | [ | |
T9W | [ | |
CiMAM | [ | |
Eukaryotic | ||
S.cerevisiae | CecropinXJ | [ |
Cecropin P1 | [ | |
P.pastoris | Cecropin AD | [ |
PaDef | [ | |
Melittin | [ | |
Fowlicidin-2 | [ | |
HKABF | [ | |
Mytichitin-A | [ | |
ABP-CM4 | [ | |
C.reinhardtii | 3×Mytichitin-A | [ |
Bacteriocin LS2 | [ | |
ToAMP4 | [ | |
Mytichitin-CB | [ |
Tab. 1 Expression system of antimicrobial peptides in this review
Expression system and engineered microorganism | Antimicrobial peptides | References |
---|---|---|
Prokaryotic | ||
E. coli | Cecropin | [ |
Perinerin | [ | |
Adenoregulin | [ | |
Abaecin | [ | |
Hep-A200 | [ | |
MLH | [ | |
Hal18 | [ | |
Plectasin | [ | |
Lactoferricin | [ | |
Buforin II | [ | |
B.subtilis | Cecropin AD | [ |
Cathelicidin-BF | [ | |
T9W | [ | |
CiMAM | [ | |
Eukaryotic | ||
S.cerevisiae | CecropinXJ | [ |
Cecropin P1 | [ | |
P.pastoris | Cecropin AD | [ |
PaDef | [ | |
Melittin | [ | |
Fowlicidin-2 | [ | |
HKABF | [ | |
Mytichitin-A | [ | |
ABP-CM4 | [ | |
C.reinhardtii | 3×Mytichitin-A | [ |
Bacteriocin LS2 | [ | |
ToAMP4 | [ | |
Mytichitin-CB | [ |
AMPs | Indication | Deliever | Status | Clinical trial identifiers |
---|---|---|---|---|
Daptomycin | Bacterial skin infections | Intravenous | Approved | NCT01211470 |
Vancomycin | Staphylococcal infections | Intravenous | Approved | NCT00175370 |
Dalbavancin (BI397, Dalvance, Xydalba) | Acute bacterial skin infections | Intravenous | Approved | NCT03233438 |
Colistin | Multidrug-resistant Gram-negative infections | Intravenous | Approved | NCT03397914 |
Tab. 2 Name, indication, deliever and clinical trial identification of antimicrobial peptides approved by US Food and Drug Administration (FDA)[6, 114-116]
AMPs | Indication | Deliever | Status | Clinical trial identifiers |
---|---|---|---|---|
Daptomycin | Bacterial skin infections | Intravenous | Approved | NCT01211470 |
Vancomycin | Staphylococcal infections | Intravenous | Approved | NCT00175370 |
Dalbavancin (BI397, Dalvance, Xydalba) | Acute bacterial skin infections | Intravenous | Approved | NCT03233438 |
Colistin | Multidrug-resistant Gram-negative infections | Intravenous | Approved | NCT03397914 |
1 | GONG T, FU J, SHI L X, et al. Antimicrobial peptides in gut health: a review[J]. Frontiers in Nutrition, 2021, 8: 751010. |
2 | PEN G H, YANG N, TENG D, et al. A review on the use of antimicrobial peptides to combat porcine viruses[J]. Antibiotics, 2020, 9(11): 801. |
3 | MONTALVO G, VANDENBERGHE L, SOCCOL V T, et al. The antihypertensive, antimicrobial and anticancer peptides from arthrospira with therapeutic potential: a mini review[J]. Current Molecular Medicine, 2020, 20(8): 593-606. |
4 | VINEETH KUMAR T V, SANIL G. A review of the mechanism of action of amphibian antimicrobial peptides focusing on peptide-membrane interaction and membrane curvature[J]. Current Protein & Peptide Science, 2017, 18(12): 1263-1272. |
5 | LEE J K, LUCHIAN T, PARK Y. New antimicrobial peptide kills drug-resistant pathogens without detectable resistance[J]. Oncotarget, 2018, 9(21): 15616-15634. |
6 | ZHANG Q Y, YAN Z B, MENG Y M, et al. Antimicrobial peptides: mechanism of action, activity and clinical potential[J]. Military Medical Research, 2021, 8(1): 48. |
7 | FOX J L. Antimicrobial peptides stage a comeback[J]. Nature Biotechnology, 2013, 31(5): 379-382. |
8 | PASUPULETI M, SCHMIDTCHEN A, MALMSTEN M. Antimicrobial peptides: key components of the innate immune system[J]. Critical Reviews in Biotechnology, 2012, 32(2): 143-171. |
9 | SLAVOKHOTOVA A A, NAUMANN T A, PRICE N P J, et al. Novel mode of action of plant defense peptides-hevein-like antimicrobial peptides from wheat inhibit fungal metalloproteases[J]. FEBS Journal, 2014, 281(20): 4754-4764. |
10 | SIEBERT H C, VON DER LIETH C W, KAPTEIN R, et al. Role of aromatic amino acids in carbohydrate binding of plant lectins: laser photo chemically induced dynamic nuclear polarization study of hevein domain-containing lectins[J]. Proteins, 1997, 28(2): 268-284. |
11 | GAO G H, LIU W, DAI J X, et al. Solution structure of PAFP-S: a new knottin-type antifungal peptide from the seeds of Phytolacca americana ,[J]. Biochemistry, 2001, 40(37): 10973-10978. |
12 | JONES P M, GEORGE A M. Computational analysis of the MCoTI-II plant defence knottin reveals a novel intermediate conformation that facilitates trypsin binding[J]. Scientific Reports, 2016, 6: 23174. |
13 | SLAVOKHOTOVA A A, ROGOZHIN E A. Defense peptides from the α-hairpinin family are components of plant innate immunity[J]. Frontiers in Plant Science, 2020, 11: 465. |
14 | SU T, HAN M, CAO D, et al. Molecular and biological properties of snakins: the foremost cysteine-rich plant host defense peptides[J]. Journal of Fungi, 2020, 6(4): 220. |
15 | HOSKIN D W, RAMAMOORTHY A. Studies on anticancer activities of antimicrobial peptides[J]. Biochimica et Biophysica Acta (BBA)-Biomembranes, 2008, 1778(2): 357-375. |
16 | GANZ T, SELSTED M E, LEHRER R I. Defensins[J]. European Journal of Haematology, 2009, 44(1): 1-8. |
17 | GREER A, ZENOBIA C, DARVEAU R P. Defensins and LL-37: a review of function in the gingival epithelium[J]. Periodontology 2000, 2013, 63(1): 67-79. |
18 | DHOPLE V, KRUKEMEYER A, RAMAMOORTHY A. The human beta-defensin-3, an antibacterial peptide with multiple biological functions[J]. Biochimica et Biophysica Acta (BBA)-Biomembranes, 2006, 1758(9): 1499-1512. |
19 | BATONI G, MAISETTA G, ESIN S, et al. Human beta-defensin-3: a promising antimicrobial peptide[J]. Mini Reviews in Medicinal Chemistry, 2006, 6(10): 1063-1073. |
20 | DELUCCA A J, BLAND J M, JACKS T J, et al. Fungicidal activity of cecropin A[J]. Antimicrobial Agents and Chemotherapy, 1997, 41(2): 481-483. |
21 | XIE W, QIU Q, WU H, et al. Expression of cecropin CMIV fusion protein in E. coli under T7 promoter[J]. Biochemistry and Molecular Biology International, 1996, 39(3): 487-492. |
22 | MENG M X, NING J F, YU J Y, et al. Antitumor activity of recombinant antimicrobial peptide penaeidin-2 against kidney cancer cells[J]. Journal of Huazhong University of Science and Technology [Medical Sciences], 2014, 34(4): 529-534. |
23 | YANG Y S, PONCET J, GARNIER J, et al. Solution structure of the recombinant penaeidin-3, a shrimp antimicrobial peptide[J]. Journal of Biological Chemistry, 2003, 278(38): 36859-36867. |
24 | PADHI A, VERGHESE B. Molecular diversity and evolution of myticin-C antimicrobial peptide variants in the Mediterranean mussel, Mytilus galloprovincialis [J]. Peptides, 2008, 29(7): 1094-1101. |
25 | MITTA G, HUBERT F, NOËL T, et al. Myticin, a novel cysteine-rich antimicrobial peptide isolated from haemocytes and plasma of the mussel Mytilus galloprovincialis [J]. European Journal of Biochemistry, 1999, 265(1): 71-78. |
26 | SABZEVARI R, ROUSHANDEH A M, MEHDIPOUR A, et al. SA/G hydrogel containing hCAP-18/LL-37-engineered WJ-MSCs-derived conditioned medium promoted wound healing in rat model of excision injury[J]. Life Sciences, 2020, 261: 118381. |
27 | CHAKRABORTY K, GHOSH S, KOLEY H, et al. Bacterial exotoxins downregulate cathelicidin (hCAP-18/LL-37) and human beta-defensin 1 (HBD-1) expression in the intestinal epithelial cells[J]. Cellular Microbiology, 2008, 10(12): 2520-2537. |
28 | NELL M J, TJABRINGA G S, VONK M J, et al. Bacterial products increase expression of the human cathelicidin hCAP-18/LL-37 in cultured human sinus epithelial cells[J]. FEMS Immunology and Medical Microbiology, 2004, 42(2): 225-231. |
29 | FAHY R J, WEWERS M D. Pulmonary defense and the human cathelicidin hCAP-18/LL-37[J]. Immunologic Research, 2005, 31(2): 75-89. |
30 | BONANZINGA T, FERRARI M C, TANZI G, et al. The role of alpha defensin in prosthetic joint infection (PJI) diagnosis: a literature review[J]. EFORT Open Reviews, 2019, 4(1): 10-13. |
31 | WYATT M C, BESWICK A D, KUNUTSOR S K, et al. The alpha-defensin immunoassay and leukocyte esterase colorimetric strip test for the diagnosis of periprosthetic infection: a systematic review and meta-analysis[J]. The Journal of Bone and Joint Surgery American Volume, 2016, 98(12): 992-1000. |
32 | HE W, WEI D X, ZHANG J, et al. Novel bone repairing scaffold consisting of bone morphogenetic protein-2 and human beta defensin-3[J]. Journal of Biological Engineering, 2021, 15(1): 5. |
33 | NIGRO E, COLAVITA I, SARNATARO D, et al. An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule[J]. Scientific Reports, 2016, 5: 18450. |
34 | LIU H W, WEI D X, DENG J Z, et al. Combined antibacterial and osteogenic in situ effects of a bifunctional titanium alloy with nanoscale hydroxyapatite coating[J]. Artificial Cells, Nanomedicine, and Biotechnology, 2018, 46(sup3): S460-S470. |
35 | HALE J D, HANCOCK R E. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria[J]. Expert Review of Anti-Infective Therapy, 2007, 5(6): 951-959. |
36 | POWERS J P S, HANCOCK R E W. The relationship between peptide structure and antibacterial activity[J]. Peptides, 2003, 24(11): 1681-1691. |
37 | SAINT N, MARRI L, MARCHINI D, et al. The antibacterial peptide ceratotoxin a displays alamethicin-like behavior in lipid bilayers[J]. Peptides, 2003, 24(11): 1779-1784. |
38 | MURZYN K, PASENKIEWICZ-GIERULA M. Construction of a toroidal model for the magainin pore[J]. Journal of Molecular Modeling, 2003, 9(4): 217-224. |
39 | SHAI Y, OREN Z. From "carpet" mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides[J]. Peptides, 2001, 22(10): 1629-1641. |
40 | DEAN R E, O'BRIEN L M, THWAITE J E, et al. A carpet-based mechanism for direct antimicrobial peptide activity against vaccinia virus membranes[J]. Peptides, 2010, 31(11): 1966-1972. |
41 | MALINA A, SHAI Y. Conjugation of fatty acids with different lengths modulates the antibacterial and antifungal activity of a cationic biologically inactive peptide[J]. The Biochemical Journal, 2005, 390(Pt 3): 695-702. |
42 | REN L, HEN L, WEN H, et al. An anionic antimicrobial peptide from toad bombina maxima[J]. Biochemical and Biophysical Research Communications, 2002, 295(4): 796-799. |
43 | DENNISON S R, HOWE J, MORTON L H G, et al. Interactions of an anionic antimicrobial peptide with Staphylococcus aureus membranes[J]. Biochemical and Biophysical Research Communications, 2006, 347(4): 1006-1010. |
44 | LI S M, HAO L L, BAO W G, et al. A novel short anionic antibacterial peptide isolated from the skin of Xenopus laevis with broad antibacterial activity and inhibitory activity against breast cancer cell[J]. Archives of Microbiology, 2016, 198(5): 473-482. |
45 | DENNISON S R, MORTON L H, HARRIS F, et al. Low pH enhances the action of maximin H5 against Staphylococcus aureus and helps mediate lysylated phosphatidylglycerol-induced resistance[J]. Biochemistry, 2016, 55(27): 3735-3751. |
46 | KRAGOL G, LOVAS S, VARADI G, et al. The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding[J]. Biochemistry, 2001, 40(10): 3016-3026. |
47 | MANDAL S M, KHAN J, MAHATA D, et al. A self-assembled clavanin A-coated amniotic membrane scaffold for the prevention of biofilm formation by ocular surface fungal pathogens[J]. Biofouling, 2017, 33(10): 881-891. |
48 | UYTERHOEVEN E T, BUTLER C H, KO D, et al. Investigating the nucleic acid interactions and antimicrobial mechanism of buforin II[J]. FEBS Letters, 2008, 582(12): 1715-1718. |
49 | LUPETTI A, DISSEL J T, BROUWER C P J M, et al. Human antimicrobial peptides' antifungal activity against Aspergillus fumigatus [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2008, 27(11): 1125-1129. |
50 | VAN EIJK M, BOEREFIJN S, CEN L D, et al. Cathelicidin-inspired antimicrobial peptides as novel antifungal compounds[J]. Medical Mycology, 2020, 58(8): 1073-1084. |
51 | HOWELL M D, WOLLENBERG A, GALLO R L, et al. Cathelicidin deficiency predisposes to eczema herpeticum[J]. Journal of Allergy and Clinical Immunology, 2006, 117(4): 836-841. |
52 | BERGMAN P, WALTER-JALLOW L, BROLIDEN K, et al. The antimicrobial peptide LL-37 inhibits HIV-1 replication[J]. Current HIV Research, 2007, 5(4): 410-415. |
53 | HOWELL M D, JONES J F, KISICH K O, et al. Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum[J]. Journal of Immunology, 2004, 172(3): 1763-1767. |
54 | LIU X W, WEI D X, ZHONG J, et al. Electrospun nanofibrous P(DLLA-CL) balloons as calcium phosphate cement filled containers for bone repair: in vitro and in vivo studies[J]. ACS Applied Materials & Interfaces, 2015, 7(33): 18540-18552. |
55 | PITALE D M, KAUR G, BAGHEL M, et al. Halictine-2 antimicrobial peptide shows promising anti-parasitic activity against Leishmania spp[J]. Experimental Parasitology, 2020, 218: 107987. |
56 | FANG Y Q, HE X Q, ZHANG P C, et al. In vitro and in vivo antimalarial activity of LZ1, a peptide derived from snake cathelicidin[J]. Toxins, 2019, 11(7): 379. |
57 | RAJA Z, ANDRÉ S, ABBASSI F, et al. Insight into the mechanism of action of temporin-SHa, a new broad-spectrum antiparasitic and antibacterial agent[J]. PLoS One, 2017, 12(3): e0174024. |
58 | ZHENG L B, QIU J Y, LIU H H, et al. Molecular characterization and antiparasitic activity analysis of a novel piscidin 5-like type 4 from Larimichthys crocea[J]. Molecular Immunology, 2021, 129: 12-20. |
59 | GRABNER A N, ALFONSO J, KAYANO A M, et al. BmajPLA2-II, a basic Lys49-phospholipase A2 homologue from Bothrops marajoensis snake venom with parasiticidal potential[J]. International Journal of Biological Macromolecules, 2017, 102: 571-581. |
60 | VAEZI Z, BORTOLOTTI A, LUCA V, et al. Aggregation determines the selectivity of membrane-active anticancer and antimicrobial peptides: the case of killerFLIP[J]. Biochimica et Biophysica Acta (BBA)-Biomembranes, 2020, 1862(2): 183107. |
61 | FLORES-ALVAREZ L J, GUZMÁN-RODRÍGUEZ J J, LÓPEZ-GÓMEZ R, et al. PaDef defensin from avocado (Persea americana var. drymifolia) is cytotoxic to K562 chronic myeloid leukemia cells through extrinsic apoptosis[J]. The International Journal of Biochemistry & Cell Biology, 2018, 99: 10-18. |
62 | QIN X C, ZHU G F, HUANG L X, et al. LL-37 and its analog FF/CAP18 attenuate neutrophil migration in sepsis-induced acute lung injury[J]. Journal of Cellular Biochemistry, 2019, 120(4): 4863-4871. |
63 | ZHANG H D, HAN D J, LÜ T T, et al. Novel peptide myristoly-CM4 induces selective cytotoxicity in leukemia K562/MDR and Jurkat cells by necrosis and/or apoptosis pathway[J]. Drug Design, Development and Therapy, 2019, 13: 2153-2167. |
64 | JUNG Y, KONG B, MOON S, et al. Envelope-deforming antiviral peptide derived from influenza virus M2 protein[J]. Biochemical and Biophysical Research Communications, 2019, 517(3): 507-512. |
65 | WU Y M, CHEN K, WU X, et al. Superfast and water-insensitive polymerization on α-amino acid N-carboxyanhydrides to prepare polypeptides using tetraalkylammonium carboxylate as the initiator[J]. Angewandte Chemie International Edition, 2021, 60(50): 26063-26071. |
66 | ZHOU M, ZOU J C, LIU L Q, et al. Synthesis of poly-α/β-peptides with tunable sequence via the copolymerization on N-carboxyanhydride and N-thiocarboxyanhydride[J]. iScience, 2021, 24(10): 103124. |
67 | ZHOU M, XIAO X M, CONG Z H, et al. Water-insensitive synthesis of poly-β-peptides with defined architecture[J]. Angewandte Chemie International Edition, 2020, 59(18): 7240-7244. |
68 | MIKUT R. Computer-based analysis, visualization, and interpretation of antimicrobial peptide activities[J]. Methods in Molecular Biology, 2010, 618: 287-299. |
69 | BOMAN H G, AGERBERTH B, BOMAN A. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine[J]. Infection and Immunity, 1993, 61(7): 2978-2984. |
70 | SILVESTRO L, WEISER J N, AXELSEN P H. Antibacterial and antimembrane activities of cecropin A in Escherichia coli [J]. Antimicrobial Agents and Chemotherapy, 2000, 44(3): 602-607. |
71 | WANG L, WU H, DOU F, et al. High-level expression of cecropin CMIV in E. coli from a fusion construct containing the human tumor necrosis factor[J]. Biochemistry and Molecular Biology International, 1997, 41(5): 1051-1056. |
72 | XU X X, JIN F L, YU X Q, et al. Expression and purification of a recombinant antibacterial peptide, cecropin, from Escherichia coli [J]. Protein Expression and Purification, 2007, 53(2): 293-301. |
73 | ZHOU Q F, LUO X G, YE L, et al. High-level production of a novel antimicrobial peptide perinerin in Escherichia coli by fusion expression[J]. Current Microbiology, 2007, 54(5): 366-370. |
74 | CAO W, ZHOU Y X, MA Y S, et al. Expression and purification of antimicrobial peptide adenoregulin with C-amidated terminus in Escherichia coli [J]. Protein Expression and Purification, 2005, 40(2): 404-410. |
75 | KIM D S, KIM S W, SONG J M, et al. A new prokaryotic expression vector for the expression of antimicrobial peptide abaecin using SUMO fusion tag[J]. BMC Biotechnology, 2019, 19(1): 13. |
76 | COSTA A DA, PEREIRA A M, GOMES A C, et al. Production of bioactive hepcidin by recombinant DNA tagging with an elastin-like recombinamer[J]. New Biotechnology, 2018, 46: 45-53. |
77 | GONG G L, WEI Y, WANG Z Z. Functional expression, purification, and antimicrobial activity of a novel antimicrobial peptide MLH in Escherichia coli [J]. Preparative Biochemistry & Biotechnology, 2018, 48(1): 57-63. |
78 | WEI Q D, KIM Y S, SEO J H, et al. Facilitation of expression and purification of an antimicrobial peptide by fusion with baculoviral polyhedrin in Escherichia coli [J]. Applied and Environmental Microbiology, 2005, 71(9): 5038-5043. |
79 | JING X L, LUO X G, TIAN W J, et al. High-level expression of the antimicrobial peptide plectasin in Escherichia coli [J]. Current Microbiology, 2010, 61(3): 197-202. |
80 | KIM H K, CHUN D S, KIM J S, et al. Expression of the cationic antimicrobial peptide lactoferricin fused with the anionic peptide in Escherichia coli [J]. Applied Microbiology and Biotechnology, 2006, 72(2): 330-338. |
81 | LEE J H, MINN I, PARK C B, et al. Acidic peptide-mediated expression of the antimicrobial peptide buforin II as tandem repeats in Escherichia coli [J]. Protein Expression and Purification, 1998, 12(1): 53-60. |
82 | WANG Q, ZHU F F, XIN Y Q, et al. Expression and purification of antimicrobial peptide buforin IIb in Escherichia coli [J]. Biotechnology Letters, 2011, 33(11): 2121-2126. |
83 | CHEN X, ZHU F M, CAO Y H, et al. Novel expression vector for secretion of cecropin AD in Bacillus subtilis with enhanced antimicrobial activity[J]. Antimicrobial Agents and Chemotherapy, 2009, 53(9): 3683-3689. |
84 | LUAN C, ZHANG H W, SONG D G, et al. Expressing antimicrobial peptide cathelicidin-BF in Bacillus subtilis using SUMO technology[J]. Applied Microbiology and Biotechnology, 2014, 98(8): 3651-3658. |
85 | ZHANG L C, LI G Q, ZHAN N, et al. Expression of a Pseudomonas aeruginosa-targeted antimicrobial peptide T9W in Bacillus subtilis using a maltose-inducible vector[J]. Process Biochemistry, 2019, 81: 22-27. |
86 | LEE B C, TSAI J C, LIN C Y, et al. Using Bacillus subtilis as a host cell to express an antimicrobial peptide from the marine chordate ciona intestinalis[J]. Marine Drugs, 2021, 19(2): 111. |
87 | XIA L J, LIU Z Y, MA J, et al. Expression, purification and characterization of cecropin antibacterial peptide from Bombyx mori in Saccharomyces cerevisiae [J]. Protein Expression and Purification, 2013, 90(1): 47-54. |
88 | JIANG R J, ZHANG P F, WU X L, et al. Expression of antimicrobial peptide cecropin P1 in Saccharomyces cerevisiae and its antibacterial and antiviral activity in vitro [J]. Electronic Journal of Biotechnology, 2021, 50: 16-22. |
89 | AHMAD M, HIRZ M, PICHLER H, et al. Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production[J]. Applied Microbiology and Biotechnology, 2014, 98(12): 5301-5317. |
90 | MENG D M, ZHAO J F, LING X, et al. Recombinant expression, purification and antimicrobial activity of a novel antimicrobial peptide PaDef in Pichia pastoris [J]. Protein Expression and Purification, 2017, 130: 90-99. |
91 | MORIDI K, HEMMATY M, AKBARI EIDGAHI M R, et al. Construction, cloning, and expression of Melittin antimicrobial peptide using Pichia pastoris expression system[J]. Gene Reports, 2020, 21: 100900. |
92 | XING L W, TIAN S X, GAO W, et al. Recombinant expression and biological characterization of the antimicrobial peptide fowlicidin-2 in Pichia pastoris [J]. Experimental and Therapeutic Medicine, 2016, 12(4): 2324-2330. |
93 | WANG L, LAI C E, WU Q F, et al. Production and characterization of a novel antimicrobial peptide HKABF by Pichia pastoris [J]. Process Biochemistry, 2008, 43(10): 1124-1131. |
94 | MENG D M, DAI H X, GAO X F, et al. Expression, purification and initial characterization of a novel recombinant antimicrobial peptide Mytichitin-A in Pichia pastoris [J]. Protein Expression and Purification, 2016, 127: 35-43. |
95 | ZHANG J, ZHANG S Q, WU X, et al. Expression and characterization of antimicrobial peptide ABP-CM4 in methylotrophic yeast Pichia pastoris [J]. Process Biochemistry, 2006, 41(2): 251-256. |
96 | DONG B, CHENG R Q, LIU Q Y, et al. Multimer of the antimicrobial peptide Mytichitin - A expressed in Chlamydomonas reinhardtii exerts a broader antibacterial spectrum and increased potency[J]. Journal of Bioscience and Bioengineering, 2018, 125(2): 175-179. |
97 | LI A G, HUANG R H, WANG C G, et al. Expression of anti-lipopolysaccharide factor isoform 3 in Chlamydomonas reinhardtii showing high antimicrobial activity[J]. Marine Drugs, 2021, 19(5): 239. |
98 | XUE B, DONG C M, HU H H, et al. Chlamydomonas reinhardtii-expressed multimer of ToAMP4 inhibits the growth of bacteria of both Gram-positive and Gram-negative[J]. Process Biochemistry, 2020, 91: 311-318. |
99 | HADIATULLAH H, WANG H, LIU Y X, et al. Chlamydomonas reinhardtii-derived multimer Mytichitin-CB possesses potent antibacterial properties[J]. Process Biochemistry, 2020, 96: 21-29. |
100 | CHAHARDOLI M, FAZELI A, NIAZI A, et al. Recombinant expression of LFchimera antimicrobial peptide in a plant-based expression system and its antimicrobial activity against clinical and phytopathogenic bacteria[J]. Biotechnology & Biotechnological Equipment, 2018, 32(3): 714-723. |
101 | LI C, BLENCKE H M, PAULSEN V, et al. Powerful workhorses for antimicrobial peptide expression and characterization[J]. Bioengineered Bugs, 2010, 1(3): 217-220. |
102 | SINHA R, SHUKLA P. Antimicrobial peptides: recent insights on biotechnological interventions and future perspectives[J]. Protein and Peptide Letters, 2019, 26(2): 79-87. |
103 | ISHIDA H, NGUYEN L T, GOPAL R, et al. Overexpression of antimicrobial, anticancer, and transmembrane peptides in Escherichia coli through a calmodulin-peptide fusion system[J]. Journal of the American Chemical Society, 2016, 138(35): 11318-11326. |
104 | SCHÜTZ M, SCHÖPPE J, SEDLÁK E, et al. Directed evolution of G protein-coupled receptors in yeast for higher functional production in eukaryotic expression hosts[J]. Scientific Reports, 2016, 6: 21508. |
105 | KARBALAEI M, REZAEE S A, FARSIANI H. Pichia pastoris: a highly successful expression system for optimal synthesis of heterologous proteins[J]. Journal of Cellular Physiology, 2020, 235(9): 5867-5881. |
106 | BI X N, WANG C, DONG W B, et al. Antimicrobial properties and interaction of two Trp-substituted cationic antimicrobial peptides with a lipid bilayer[J]. The Journal of Antibiotics, 2014, 67(5): 361-368. |
107 | TRIPATHI A K, KUMARI T, TANDON A, et al. Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat[J]. Acta Biomaterialia, 2017, 57: 170-186. |
108 | SUN Y, DONG W B, SUN L, et al. Insights into the membrane interaction mechanism and antibacterial properties of chensinin-1b[J]. Biomaterials, 2015, 37: 299-311. |
109 | DONG W B, MAO X M, GUAN Y, et al. Antimicrobial and anti-inflammatory activities of three chensinin-1 peptides containing mutation of glycine and histidine residues[J]. Scientific Reports, 2017, 7: 40228. |
110 | CARDOSO M H, OROZCO R Q, REZENDE S B, et al. Computer-aided design of antimicrobial peptides: are we generating effective drug candidates? [J]. Frontiers in Microbiology, 2020, 10: 3097. |
111 | LEE E Y, FULAN B M, WONG G C L, et al. Mapping membrane activity in undiscovered peptide sequence space using machine learning[J]. Proceedings of the National Academy of Sciences of the United States of America, 2016, 113(48): 13588-13593. |
112 | DAS P, SERCU T, WADHAWAN K, et al. Accelerated antimicrobial discovery via deep generative models and molecular dynamics simulations[J]. Nature Biomedical Engineering, 2021, 5(6): 613-623. |
113 | PARK J W, YU J H, KIM S-W, et al. Enhancement of antimicrobial peptide genes expression in cactus mutated Bombyx mori cells by CRISPR/Cas9[J]. International Journal of Industrial Entomology, 2018, 37(1): 21-28. |
114 | MOOKHERJEE N, ANDERSON M A, HAAGSMAN H P, et al. Antimicrobial host defence peptides: functions and clinical potential[J]. Nature Reviews Drug Discovery, 2020, 19(5): 311-332. |
115 | MCCARTHY M W, KEYLOUN K R, GILLARD P, et al. Dalbavancin reduces hospital stay and improves productivity for patients with acute bacterial skin and skin structure infections: the ENHANCE trial[J]. Infectious Diseases and Therapy, 2020, 9(1): 53-67. |
116 | BÜYÜKKIRAZ M E, KESMEN Z. Antimicrobial peptides (AMPs): a promising class of antimicrobial compounds[J]. Journal of Applied Microbiology, 2022, 132(3): 1573-1596. |
117 | BAREFOOT S F, KLAENHAMMER T R. Detection and activity of lactacin B, a bacteriocin produced by Lactobacillus acidophilus [J]. Applied and Environmental Microbiology, 1983, 45(6): 1808-1815. |
118 | CHEIGH C I, PYUN Y R. Nisin biosynthesis and its properties[J]. Biotechnology Letters, 2005, 27(21): 1641-1648. |
119 | DE ARAUZ L J, JOZALA A F, MAZZOLA P G, et al. Nisin biotechnological production and application: a review[J]. Trends in Food Science & Technology, 2009, 20(3/4): 146-154. |
120 | GALVÁN MÁRQUEZ I J, MCKAY B, WONG A, et al. Mode of action of nisin on Escherichia coli [J]. Canadian Journal of Microbiology, 2020, 66(2): 161-168. |
121 | FIELD D, BAGHOU I, REA M C, et al. Nisin in combination with cinnamaldehyde and EDTA to control growth of Escherichia coli strains of swine origin[J]. Antibiotics, 2017, 6(4): 35 |
122 | TONG Z C, ZHANG Y J, LING J Q, et al. An in vitro study on the effects of nisin on the antibacterial activities of 18 antibiotics against Enterococcus faecalis [J]. PLoS One, 2014, 9(2): e89209. |
123 | CASCIARO B, LOFFREDO M R, LUCA V, et al. Esculentin-1a derived antipseudomonal peptides: limited induction of resistance and synergy with aztreonam[J]. Protein and Peptide Letters, 2018, 25(12): 1155-1162. |
124 | ARCIOLA C R, CAMPOCCIA D, MONTANARO L. Implant infections: adhesion, biofilm formation and immune evasion[J]. Nature Reviews Microbiology, 2018, 16(7): 397-409. |
125 | CRÉMET L, BROQUET A, JACQUELINE C, et al. Innate immune evasion of Escherichia coli clinical strains from orthopedic implant infections[J]. European Journal of Clinical Microbiology & Infectious Diseases, 2016, 35(6): 993-999. |
126 | LEVY O, SISSON R B, FRYER H E, et al. Neutrophil defense in patients undergoing bone marrow transplantation: bactericidal/permeability-increasing protein (BPI) and defensins in graft-derived neutrophils[J]. Transplantation, 2002, 73(9): 1522-1526. |
127 | HOOVER D M, BOULEGUE C, YANG D, et al. The structure of human macrophage inflammatory protein-3alpha/CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins[J]. The Journal of Biological Chemistry, 2002, 277(40): 37647-37654. |
128 | AGERBERTH B, CHARO J, WERR J, et al. The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations[J]. Blood, 2000, 96(9): 3086-3093. |
129 | BLOMQVIST M, BERGQUIST J, WESTMAN A, et al. Identification of defensins in human lymphocyte nuclei[J]. European Journal of Biochemistry, 1999, 263(2): 312-318. |
130 | SRIVASTAVA M D, SRIVASTAVA B I S. Expression of mRNA and proteins for toll-like receptors, associated molecules, defensins and LL-37 by SRIK-NKL, a CD8+ NK/T cell line[J]. Leukemia Research, 2005, 29(7): 813-820. |
131 | HOLLY M K, DIAZ K, SMITH J G. Defensins in viral infection and pathogenesis[J]. Annual Review of Virology, 2017, 4(1): 369-391. |
132 | NIYONSABA F, USHIO H, NAKANO N, et al. Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines[J]. The Journal of Investigative Dermatology, 2007, 127(3): 594-604. |
133 | MI B B, LIU J, LIU Y, et al. The designer antimicrobial peptide A-hBD-2 facilitates skin wound healing by stimulating keratinocyte migration and proliferation[J]. Cellular Physiology and Biochemistry, 2018, 51(2): 647-663. |
134 | BARLOW P G, SVOBODA P, MACKELLAR A, et al. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37[J]. PLoS One, 2011, 6(10): e25333. |
135 | TRIPATHI S, TECLE T, VERMA A, et al. The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins[J]. The Journal of General Virology, 2013, 94(Pt 1): 40-49. |
136 | TODOROV S D, WACHSMAN M B, KNOETZE H, et al. An antibacterial and antiviral peptide produced by Enterococcus mundtii ST4V isolated from soya beans[J]. International Journal of Antimicrobial Agents, 2005, 25(6): 508-513. |
137 | LIANG X L, ZHANG X J, LIAN K Q, et al. Antiviral effects of bovine antimicrobial peptide against TGEV in vivo and in vitro [J]. Journal of Veterinary Science, 2020, 21(5): e80. |
138 | MARCOCCI M E, AMATORE D, VILLA S, et al. The amphibian antimicrobial peptide temporin B inhibits in vitro herpes simplex virus 1 infection[J]. Antimicrobial Agents and Chemotherapy, 2018, 62(5): e02367-e02317. |
139 | BHATTACHARYA R, GUPTA A M, MITRA S, et al. A natural food preservative peptide nisin can interact with the SARS-CoV-2 spike protein receptor human ACE2[J]. Virology, 2021, 552: 107-111. |
140 | KURPE S R, GRISHIN S Y, SURIN A K, et al. Antimicrobial and amyloidogenic activity of peptides. can antimicrobial peptides be used against SARS-CoV-2? [J]. International Journal of Molecular Sciences, 2020, 21(24): 9552. |
141 | PENG X L, CHENG J S, GONG H L, et al. Advances in the design and development of SARS-CoV-2 vaccines[J]. Military Medical Research, 2021, 8(1): 67. |
142 | JIN G, WEINBERG A. Human antimicrobial peptides and cancer[J]. Seminars in Cell & Developmental Biology, 2019, 88: 156-162. |
143 | YANG Y Q, ZHANG H D, WANYAN Y K, et al. Effect of hydrophobicity on the anticancer activity of fatty-acyl-conjugated CM4 in breast cancer cells[J]. ACS Omega, 2020, 5(34): 21513-21523. |
144 | MAIJAROEN S, JANGPROMMA N, DADUANG J, et al. KT2 and RT2 modified antimicrobial peptides derived from Crocodylus siamensis Leucrocin I show activity against human colon cancer HCT-116 cells[J]. Environmental Toxicology and Pharmacology, 2018, 62: 164-176. |
145 | WANG D M, JIAO X, PLOTNIKOFF N P, et al. Killing effect of methionine enkephalin on melanoma in vivo and in vitro [J]. Oncology Reports, 2017, 38(4): 2132-2140. |
146 | WEI D X, DAO J W, CHEN G Q. A micro-ark for cells: highly open porous polyhydroxyalkanoate microspheres as injectable scaffolds for tissue regeneration[J]. Advanced Materials, 2018, 30(31): e1802273. |
147 | RAHMAN M, PENG X L, ZHAO X H, et al. 3D bioactive cell-free-scaffolds for in-vitro/in-vivo capture and directed osteoinduction of stem cells for bone tissue regeneration[J]. Bioactive Materials, 2021, 6(11): 4083-4095. |
148 | WEI D X, QIAO R R, DAO J W, et al. Soybean lecithin-mediated nanoporous PLGA microspheres with highly entrapped and controlled released BMP-2 as a stem cell platform[J]. Small, 2018, 14(22): e1800063. |
149 | FAN L, HE Z J, PENG X L, et al. Injectable, intrinsically antibacterial conductive hydrogels with self-healing and pH stimulus responsiveness for epidermal sensors and wound healing[J]. ACS Applied Materials & Interfaces, 2021, 13(45): 53541-53552. |
150 | FAN L, XIE J L, ZHENG Y P, et al. Antibacterial, self-adhesive, recyclable, and tough conductive composite hydrogels for ultrasensitive strain sensing[J]. ACS Applied Materials & Interfaces, 2020, 12(19): 22225-22236. |
151 | WEI D X, DAO J W, LIU H W, et al. Suspended polyhydroxyalkanoate microspheres as 3D carriers for mammalian cell growth[J]. Artificial Cells, Nanomedicine, and Biotechnology, 2018, 46(sup2): 473-483. |
152 | XU N, PENG X L, LI H R, et al. Marine-derived collagen as biomaterials for human health[J]. Frontiers in Nutrition, 2021, 8: 702108. |
153 | CHEN L, SHAO L P, WANG F P, et al. Enhancement in sustained release of antimicrobial peptide and BMP-2 from degradable three dimensional-printed PLGA scaffold for bone regeneration[J]. RSC Advances, 2019, 9(19): 10494-10507. |
154 | LIU Z P, YUAN X, LIU M, et al. Antimicrobial peptide combined with BMP2-modified mesenchymal stem cells promotes calvarial repair in an osteolytic model[J]. Molecular Therapy, 2018, 26(1): 199-207. |
155 | MARTIN-GÓMEZ H, OLIVER-CERVELLÓ L, BUXADERA-PALOMERO J, et al. Chemically diverse multifunctional peptide platforms with antimicrobial and cell adhesive properties[J]. Chembiochem: a European Journal of Chemical Biology, 2021, 22(5): 839-844. |
156 | LIN Z F, WU T T, WANG W S, et al. Biofunctions of antimicrobial peptide-conjugated alginate/hyaluronic acid/collagen wound dressings promote wound healing of a mixed-bacteria-infected wound[J]. International Journal of Biological Macromolecules, 2019, 140: 330-342. |
157 | ITO A, TAKAHASHI T, KAWABE Y, et al. Human beta defensin-3 engineered keratinocyte sheets constructed by a magnetic force-based tissue engineering technique[J]. Journal of Bioscience and Bioengineering, 2009, 108(3): 244-247. |
158 | KITTAKA M, SHIBA H, KAJIYA M, et al. The antimicrobial peptide LL37 promotes bone regeneration in a rat calvarial bone defect[J]. Peptides, 2013, 46: 136-142. |
159 | SCHWEIZER F. Cationic amphiphilic peptides with cancer-selective toxicity[J]. European Journal of Pharmacology, 2009, 625(1/2/3): 190-194. |
160 | HANCOCK R E W, SAHL H G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies[J]. Nature Biotechnology, 2006, 24(12): 1551-1557. |
161 | CHEN R, YU J M, GONG H L, et al. An easy long-acting BMP7 release system based on biopolymer nanoparticles for inducing osteogenic differentiation of adipose mesenchymal stem cells[J]. Journal of Tissue Engineering and Regenerative Medicine, 2020, 14(7): 964-972. |
162 | HU J, WANG M, XIAO X Y, et al. A novel long-acting azathioprine polyhydroxyalkanoate nanoparticle enhances treatment efficacy for systemic lupus erythematosus with reduced side effects[J]. Nanoscale, 2020, 12(19): 10799-10808. |
163 | ZHAO X H, PENG X L, GONG H L, et al. Osteogenic differentiation system based on biopolymer nanoparticles for stem cells in simulated microgravity[J]. Biomedical Materials, 2021, 16(4): 044102. |
164 | RADAIC A, DE JESUS M B, KAPILA Y L. Bacterial anti-microbial peptides and nano-sized drug delivery systems: the state of the art toward improved bacteriocins[J]. Journal of Controlled Release, 2020, 321: 100-118. |
165 | LAM S J, O'BRIEN-SIMPSON N M, PANTARAT N, et al. Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers[J]. Nature Microbiology, 2016, 1(11): 16162. |
166 | NIEMIROWICZ K, PROKOP I, WILCZEWSKA A Z, et al. Magnetic nanoparticles enhance the anticancer activity of cathelicidin LL-37 peptide against colon cancer cells[J]. International Journal of Nanomedicine, 2015, 10: 3843-3853. |
167 | CARRATALÁ J V, SERNA N, VILLAVERDE A, et al. Nanostructured antimicrobial peptides: the last push towards clinics[J]. Biotechnology Advances, 2020, 44: 107603. |
168 | FALCIANI C, ZEVOLINI F, BRUNETTI J, et al. Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections[J]. International Journal of Nanomedicine, 2020, 15: 1117-1128. |
169 | NYSTRÖM L, STRÖMSTEDT A A, SCHMIDTCHEN A, et al. Peptide-loaded microgels as antimicrobial and anti-inflammatory surface coatings[J]. Biomacromolecules, 2018, 19(8): 3456-3466. |
170 | NIEMIROWICZ K, DURNAŚ B, TOKAJUK G, et al. Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13[J]. Scientific Reports, 2017, 7: 4610. |
171 | FINDLAY F, POHL J, SVOBODA P, et al. Carbon nanoparticles inhibit the antimicrobial activities of the human cathelicidin LL-37 through structural alteration[J]. Journal of Immunology, 2017, 199(7): 2483-2490. |
172 | WU J, YANG J, WANG X F, et al. A frog cathelicidin peptide effectively promotes cutaneous wound healing in mice[J]. The Biochemical Journal, 2018, 475(17): 2785-2799. |
173 | THAPA R K, DIEP D B, TØNNESEN H H. Topical antimicrobial peptide formulations for wound healing: current developments and future prospects[J]. Acta Biomaterialia, 2020, 103: 52-67. |
174 | YOO J H, HO S, TRAN D H Y, et al. Anti-fibrogenic effects of the anti-microbial peptide cathelicidin in murine colitis-associated fibrosis[J]. Cellular and Molecular Gastroenterology and Hepatology, 2015, 1(1): 55-74.e1. |
175 | RAMOS R, SILVA J P, RODRIGUES A C, et al. Wound healing activity of the human antimicrobial peptide LL37[J]. Peptides, 2011, 32(7): 1469-1476. |
176 | GAUGLITZ G G, BUREIK D, ZWICKER S, et al. The antimicrobial peptides psoriasin (S100A7) and koebnerisin (S100A15) suppress extracellular matrix production and proliferation of human fibroblasts[J]. Skin Pharmacology and Physiology, 2015, 28(3): 115-123. |
177 | KANAZAWA K, OKUMURA K, OGAWA H, et al. An antimicrobial peptide with angiogenic properties, AG-30/5C, activates human mast cells through the MAPK and NF-κB pathways[J]. Immunologic Research, 2016, 64(2): 594-603. |
178 | ROY S, GANGULY A, HAQUE M, et al. Angiogenic host defense peptide AG-30/5C and bradykinin B2 receptor antagonist icatibant are G protein biased agonists for MRGPRX2 in mast cells[J]. Journal of Immunology, 2019, 202(4): 1229-1238. |
179 | CHUNG E M C, DEAN S N, PROPST C N, et al. Komodo dragon-inspired synthetic peptide DRGN-1 promotes wound-healing of a mixed-biofilm infected wound[J]. Npj Biofilms and Microbiomes, 2017, 3: 9. |
180 | KIM D H, HWANG J S, LEE I H, et al. The insect peptide CopA3 increases colonic epithelial cell proliferation and mucosal barrier function to prevent inflammatory responses in the gut[J]. Journal of Biological Chemistry, 2016, 291(7): 3209-3223. |
181 | LUONG H X, THANH T T, TRAN T H. Antimicrobial peptides-advances in development of therapeutic applications[J]. Life Sciences, 2020, 260: 118407. |
182 | SEO M D, WON H S, KIM J H, et al. Antimicrobial peptides for therapeutic applications: a review[J]. Molecules, 2012, 17(10): 12276-12286. |
183 | KANG H K, KIM C, SEO C H, et al. The therapeutic applications of antimicrobial peptides (AMPs): a patent review[J]. Journal of Microbiology, 2017, 55(1): 1-12. |
184 | ZHANG G L, SUNKARA L T. Avian antimicrobial host defense peptides: from biology to therapeutic applications[J]. Pharmaceuticals, 2014, 7(3): 220-247. |
185 | SPALLER B L, TRIEU J M, ALMEIDA P F. Hemolytic activity of membrane-active peptides correlates with the thermodynamics of binding to 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine bilayers[J]. The Journal of Membrane Biology, 2013, 246(3): 257-262. |
186 | WEI H Q, XIE Z P, TAN X C, et al. Temporin-like peptides show antimicrobial and anti-biofilm activities against Streptococcus mutans with reduced hemolysis[J]. Molecules, 2020, 25(23): 5724. |
187 | TOROPOVA A P, TOROPOV A A, BEEG M, et al. Utilization of the Monte Carlo method to build up QSAR models for hemolysis and cytotoxicity of antimicrobial peptides[J]. Current Drug Discovery Technologies, 2017, 14(4): 229-243. |
188 | SON M, LEE Y R, HWANG H, et al. Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides[J]. ChemMedChem, 2013, 8(10): 1638-1642. |
189 | PINI A, GIULIANI A, FALCIANI C, et al. Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity[J]. Journal of Peptide Science: an Official Publication of the European Peptide Society, 2007, 13(6): 393-399. |
190 | ZHANG Q H, XU Y Z, WANG Q, et al. Potential of novel antimicrobial peptide P3 from bovine erythrocytes and its analogs to disrupt bacterial membranes in vitro and display activity against drug-resistant bacteria in a mouse model[J]. Antimicrobial Agents and Chemotherapy, 2015, 59(5): 2835-2841. |
191 | LI Z J, XU X B, MENG L X, et al. Hp1404, a new antimicrobial peptide from the scorpion Heterometrus petersii [J]. PLoS One, 2014, 9(5): e97539. |
192 | EDWARDS I A, ELLIOTT A G, KAVANAGH A M, et al. Structure-activity and-toxicity relationships of the antimicrobial peptide tachyplesin-1[J]. ACS Infectious Diseases, 2017, 3(12): 917-926. |
193 | XU D, LIAO C B, ZHANG B, et al. Human enteric α-defensin 5 promotes shigella infection by enhancing bacterial adhesion and invasion[J]. Immunity, 2018, 48(6): 1233-1244.e6. |
194 | XU D, LIAO C B, XIAO J, et al. Human enteric defensin 5 promotes shigella infection of macrophages[J]. Infection and Immunity, 2019, 88(1): e00769-e00719. |
[1] | Zhidian DIAO, Xixian WANG, Qing SUN, Jian XU, Bo MA. Advances and applications of single-cell Raman spectroscopy testing and sorting equipment [J]. Synthetic Biology Journal, 2023, 4(5): 1020-1035. |
[2] | Hui LU, Fangli ZHANG, Lei HUANG. Establishment of iBioFoundry for synthetic biology applications [J]. Synthetic Biology Journal, 2023, 4(5): 877-891. |
[3] | Zhonghu BAI, He REN, Jianqi NIE, Yang SUN. The recent progresses and applications of in-parallel fermentation technology [J]. Synthetic Biology Journal, 2023, 4(5): 904-915. |
[4] | Yujie WU, Xinxin LIU, Jianhui LIU, Kaiguang Yang, Zhigang SUI, Lihua ZHANG, Yukui ZHANG. Research progress of strain screening and quantitative analysis of key molecules based on high-throughput liquid chromatography and mass spectrometry [J]. Synthetic Biology Journal, 2023, 4(5): 1000-1019. |
[5] | Zhehui HU, Juan XU, Guangkai BIAN. Application of automated high-throughput technology in natural product biosynthesis [J]. Synthetic Biology Journal, 2023, 4(5): 932-946. |
[6] | Huan LIU, Qiu CUI. Advances and applications of ambient ionization mass spectrometry in screening of microbial strains [J]. Synthetic Biology Journal, 2023, 4(5): 980-999. |
[7] | Yannan WANG, Yuhui SUN. Base editing technology and its application in microbial synthetic biology [J]. Synthetic Biology Journal, 2023, 4(4): 720-737. |
[8] | Wanqiu LIU, Xiangyang JI, Huiling XU, Yicong LU, Jian LI. Cell-free protein synthesis system enables rapid and efficient biosynthesis of restriction endonucleases [J]. Synthetic Biology Journal, 2023, 4(4): 840-851. |
[9] | Meili SUN, Kaifeng WANG, Ran LU, Xiaojun JI. Rewiring and application of Yarrowia lipolytica chassis cell [J]. Synthetic Biology Journal, 2023, 4(4): 779-807. |
[10] | Zhi SUN, Ning YANG, Chunbo LOU, Chao TANG, Xiaojing YANG. Rational design for functional topology and its applications in synthetic biology [J]. Synthetic Biology Journal, 2023, 4(3): 444-463. |
[11] | Qilong LAI, Shuai YAO, Yuguo ZHA, Hong BAI, Kang NING. Microbiome-based biosynthetic gene cluster data mining techniques and application potentials [J]. Synthetic Biology Journal, 2023, 4(3): 611-627. |
[12] | Qiaozhen MENG, Fei GUO. Applications of foldability in intelligent enzyme engineering and design: take AlphaFold2 for example [J]. Synthetic Biology Journal, 2023, 4(3): 571-589. |
[13] | Sheng WANG, Zechen WANG, Weihua CHEN, Ke CHEN, Xiangda PENG, Fafen OU, Liangzhen ZHENG, Jinyuan SUN, Tao SHEN, Guoping ZHAO. Design of synthetic biology components based on artificial intelligence and computational biology [J]. Synthetic Biology Journal, 2023, 4(3): 422-443. |
[14] | Hailong LV, Jian WANG, Hao LV, Jin WANG, Yong XU, Dayong GU. Synthetic biology for next-generation genetic diagnostics [J]. Synthetic Biology Journal, 2023, 4(2): 318-332. |
[15] | Zhaoling SHEN, Yanling WU, Tianlei YING. Synthetic biology and viral vaccine development [J]. Synthetic Biology Journal, 2023, 4(2): 333-346. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||